THK / THK株式会社 (6481)

The linear-motion-guide leader, slimmed to a pure industrial-machinery play — a real but unproven roller-screw angle on humanoid legs, into a badly overbought tape.

Investment Research · Photoncap-style deep dive · v1 of "THK" · May 14, 2026

What THK physically does

THK invented the linear motion guide — the LM guide — and the company name is an abbreviation of Toughness, High quality, Know-how. Where Harmonic Drive Systems and Nabtesco solve rotary motion, THK solves straight-line motion: how to move a heavy carriage along a rail with near-zero friction, high rigidity, and micron-level repeatability. An LM guide is a rail with precision-ground grooves and a block that rides on it via recirculating ball bearings; it is the part that lets a machine-tool table, a semiconductor wafer stage, or a 3D printer head travel precisely. THK also makes ball screws and ball splines (which convert rotary motor motion into linear thrust), LM guide actuators (the rail, screw, motor and bearing integrated into a unit), and electric and linear actuators. It is, in short, the precision-linear-motion company.

The reason this matters for the robotics theme is the humanoid leg. A humanoid robot's hip and knee joints carry the highest forces in the body — they support and propel the entire mass — and the 2026 engineering consensus is increasingly that those joints are best served not by a rotary reducer but by a linear actuator built around a planetary roller screw. A roller screw replaces a ball screw's point-contact balls with line-contact threaded rollers, so it carries several times the load in the same envelope and lasts far longer under the cyclic shock of walking. That is precisely THK's domain. THK does not make the strain-wave wrist gear (Harmonic Drive Systems) or the RV base gear (Nabtesco); THK's humanoid claim is the legs and the linear high-force joints, plus a separate angle in robot hands and grippers.

The corporate structure changed materially in 2025-2026, and it changes how to read the company. THK divested its Automotive & Transportation business, transforming itself from a two-segment company into a focused Industrial Machinery (IMS) pure-play. From the fiscal year ending December 2025 onward, the reported numbers exclude automotive entirely — so historical comparisons need care, but the resulting entity is a cleaner, higher-mix precision-motion business.

Product roadmap

The core catalogue is the LM Guide family — the SHS, SSR, HSR and SRG series spanning the size and rigidity range for machine tools, semiconductor equipment and general industrial machinery — plus the ball screw and ball spline lines and the KR/SKR LM guide actuator series that integrate motion into a ready-to-mount unit. THK also runs an FA Solutions push, layering IoT, condition-monitoring and AI-driven predictive maintenance onto the mechanical base, as part of a stated strategy to evolve from a pure component maker into a services-and-modules company.

The roadmap items that matter for this theme are the SEED Solutions actuator family and the robot-hand work. THK's SEED actuators are compact, modular electric actuators that pair with the SEED Driver — a motor driver only 20mm square — to give humanoid and service-robot integrators a small, self-contained motion building block; SEED actuators enable simple ON/OFF gripping and pinching regardless of workpiece shape. THK also developed the General-Purpose Gripper TRX, a highly compact three-finger universal gripper with a single motor, a link mechanism and an integrated controller. On the high-force side, THK's planetary roller screws are the product that maps directly to humanoid hip and knee actuators, where roller-screw load capacity and life are the differentiators against ball screws. The honest framing: THK has the right products for the humanoid leg and hand, but it has not yet announced a named, dated humanoid production design win — the roadmap is product-ready, not order-confirmed.

The financial print

THK switched to a December fiscal year-end, so FY2025 is the fiscal year ended December 2025; the FY2025 4Q investor information was released February 12, 2026, and the FY2026 1Q investor information was released May 11, 2026. Because the Automotive & Transportation business was divested, both the FY2025 actuals and the FY2026 forecast exclude automotive — so the headline numbers look smaller than the old two-segment THK. For FY2026 (year ending December 2026), THK projects revenue around ¥276 billion and operating income around ¥31 billion on the slimmed industrial-machinery base.

The genuinely positive signal is the upgrade. THK sharply raised its FY2026 first-half and full-year forecasts, citing stronger-than-expected orders in the industrial-machinery business in Japan and overseas: it now expects first-half consolidated revenue of ¥138 billion and operating income of ¥15.4 billion — gains of 8.7% and 51.0% respectively over its previous outlook. A 51% operating-income guidance raise is a real inflection, not a rounding adjustment. The counter-signal is the recent history: FY2025 second-quarter operating profit fell 29% year-over-year to ¥4.5 billion, so THK is climbing out of a soft patch rather than compounding from strength. At a JPY 7,675 share price and roughly JPY 860 billion market cap, the forward P/E of 39.2 is rich for a linear-motion maker and embeds a humanoid premium that the order book does not yet substantiate. The Q1 FY2026 print already landed on May 11, 2026; the next binary is the Q2 FY2026 result, expected around August 7, 2026 — the test of whether the raised guidance holds.

Customer mix today

THK does not publish a named-customer table; the mix reads by end-market within the now-singular Industrial Machinery segment. Machine tools are a major bucket — THK LM guides are spec'd into the machine-tool builders' platforms — alongside general industrial machinery, semiconductor and flat-panel-display manufacturing equipment, electronic-device assembly equipment, and industrial robots. The semiconductor and FPD equipment exposure is the swing factor: it drove the 2024-2025 softness and is part of the recovery now lifting guidance. With automotive gone, the residual mix is higher-margin and more clearly tied to the capex cycles of precision manufacturing.

Humanoid-specific revenue is, candidly, negligible today — it does not register as a reported slice. THK's humanoid exposure is entirely forward-looking, carried by the SEED actuators, the TRX gripper, and the planetary roller screws, none of which has a disclosed humanoid production design win. The structural-shift story THK wants investors to believe is that the 2024 case ("cyclical machine-tool and semiconductor-equipment recovery") becomes, through 2026-2028, "the same recovery plus the linear high-force humanoid leg." That is plausible — the engineering logic for roller-screw legs is sound — but it is the least-proven humanoid call in this batch. Where Harmonic Drive Systems has a co-developed micro actuator demonstrated at CES and Nabtesco has launched named compact-gear families with a quantified share estimate, THK has the right component shelf and no named customer. The honest read: you are buying an industrial-machinery recovery at 39x with a humanoid option attached that is real in engineering terms and speculative in revenue terms.

What's actually happening at the humanoid leg

The substantive question for THK is whether humanoid legs go linear, and if so, whose roller screws win. The 2026 engineering literature is increasingly clear on the first half: integrated linear motion is displacing traditional rotary systems for high-force joints, and inverted planetary roller screws deliver a far better power-to-weight ratio for the hip and knee, where distributed load contact lets a roller screw support several times a ball screw's load while maintaining long operational life. Tesla's Optimus reference architecture uses 14 linear actuators alongside its 14 rotary ones — the linear count is not a niche; it is half the body's actuators. So the demand pool THK is aiming at is genuine and large.

The mechanism that is not yet working in THK's favour is the design-win conversion. The high-volume Western humanoid program — Optimus — has routed much of its actuator supply chain to China, and the roller-screw and lead-screw content for the one-million-robot Optimus plan is being heavily sourced from Chinese makers. THK competes in the precision tier, where its roller-screw life and accuracy data is a genuine differentiator, and it has the SEED actuator system for integrators who want a packaged module. But the qualification cycle is the gate: a humanoid OEM that designs in a roller-screw supplier keeps it for the production life, and THK has not announced winning one of those sockets in production. The 2026-2027 design-win season is decisive — and until a named win prints, the humanoid leg story is an engineering thesis, not a revenue forecast.

The competitive threat / Hiwin and the Chinese roller-screw makers

THK's competitive set on the linear side is led by Taiwan's Hiwin — a credible, lower-cost, scaled LM-guide and ball-screw maker that has spent years taking share from THK in the price-sensitive industrial tier — alongside the Chinese roller-screw and lead-screw makers ramping capacity into the Optimus supply chain. The dynamic is the same oligopoly-erosion pattern seen at the rotary-gear names: a Japanese precision incumbent with the quality lead and the installed-base relationships, facing Taiwanese and Chinese challengers who price well below it and improve fast. On the humanoid leg specifically, the threat is acute precisely because it is a greenfield market — there is no THK installed base to defend, so the Chinese and Taiwanese makers compete for the roller-screw sockets from the first design cycle, on price, with no incumbency inertia working for THK.

The mitigant is that roller screws — particularly inverted planetary roller screws — are a genuinely demanding precision product, harder to manufacture to humanoid-grade life specifications than a commodity ball screw, and THK's metallurgy and grinding know-how is a real edge in that specific sub-component. But "real edge in a sub-component" is exactly the position Harmonic Drive Systems and Nabtesco are in, and it has not stopped Chinese share gains there. The realistic outcome is consistent across the whole joint layer: THK keeps the precision-tier roller-screw business and competes hard on price for the volume tier, and the question is absolute-yen growth versus share loss.

The terminal risk

THK's terminal risk is the cleanest "commoditisation before scale" case in this batch. The bull thesis requires humanoid legs to (1) go linear, (2) standardise on roller screws, and (3) source those roller screws meaningfully from THK rather than from Hiwin or Chinese makers. Each step is plausible; the conjunction is not assured. If humanoid legs instead use a rotary architecture, the linear-leg demand pool shrinks and the dollars route to the rotary-gear names. If legs do go linear but the roller-screw socket is won on price by lower-cost competitors — the most likely failure mode given the greenfield-market dynamic — THK is left as a strong industrial-machinery recovery story with a disappointingly thin humanoid attach, and the 39x multiple was overpaying for an option that did not pay off. THK's credible defences are the roller-screw manufacturing edge, the SEED actuator system as a packaged module, and the FA Solutions services layer — but none of these is yet validated by a named humanoid production order, which is why the terminal risk weighs heavier here than at the two rotary-gear leaders.

Bull / Gap / Optionality (Photoncap framing)

Bull

1. The undisputed linear-motion-guide leader, now a clean industrial-machinery pure-play. THK invented the LM guide and leads the global market. The 2025-2026 automotive divestiture removed the most cyclical, lowest-mix drag, leaving a focused, higher-margin Industrial Machinery entity — a structurally better business to own through the cycle.

2. Guidance was just raised hard. THK lifted its FY2026 first-half operating-income forecast 51.0% and revenue 8.7% on stronger-than-expected industrial-machinery orders in Japan and overseas — first-half revenue now ¥138 billion, operating income ¥15.4 billion. A 51% guidance raise is a real inflection in the order book.

3. THK owns the right products for the humanoid leg. Planetary roller screws are the 2026-consensus answer for high-force hip and knee actuators, and roller screws are core THK territory. Optimus's reference architecture alone uses 14 linear actuators — the linear demand pool is half the body, not a niche.

4. The SEED actuator system and TRX gripper give THK a packaged-module angle. SEED actuators plus the 20mm-square SEED Driver, and the single-motor three-finger TRX universal gripper, let THK sell integrators a self-contained motion building block rather than a bare component — capturing more BOM value if a design win lands.

5. The semiconductor and machine-tool capex recovery is a real near-term earnings leg. The same precision-manufacturing capex cycle lifting Nabtesco is lifting THK; the guidance raise is evidence the recovery is in the order book, not just the slideware — so the base business is improving even before any humanoid revenue.

Gap

1. The tape is badly overbought. RSI 84.8 and +41.3% versus the 50-day moving average is the most stretched setup in this batch. Even in an early-cycle theme where high RSI is momentum rather than an automatic sell, an 84.8 print signals a poor entry — the risk of a sharp 10-15% mean-reversion before any thesis development is high.

2. The humanoid story has no named production design win. Unlike Harmonic Drive Systems (CES-demonstrated co-developed micro actuator) or Nabtesco (launched compact-gear families with a share estimate), THK has the component shelf and zero disclosed humanoid production orders. The 39x multiple is paying for an unconfirmed option.

3. The humanoid leg socket is a greenfield fight THK can lose on price. With no installed base to defend, THK competes for roller-screw legs against Hiwin and Chinese makers from the first design cycle, on price, with no incumbency inertia. Greenfield markets are exactly where Japanese precision incumbents have historically lost share fastest.

4. The recent earnings base is soft, not strong. FY2025 Q2 operating profit fell 29% year-over-year to ¥4.5 billion. THK is climbing out of a soft patch on a guidance raise, not compounding from strength — if the industrial-machinery recovery stalls, the 39x multiple has no cushion and no proven humanoid revenue to fall back on.

Optionality

The trade

THK has the right shelf of products for the humanoid leg and a genuine industrial-machinery recovery in hand — but it carries the least-proven humanoid revenue path in this batch and, critically, the most overbought chart, which together drop it to Bucket C. The discipline call here is to not chase: with RSI at 84.8 and the stock +41.3% over the 50-day moving average, initiate only on a pullback into JPY 7,291-8,059 (current JPY 7,675 ±5%) and ideally toward the lower half of that band, size light at 1.0% of risk capital given the unconfirmed humanoid option and the stretched tape, and stop at JPY 6,300 (below the 50-day structure and the pre-breakout base). The Q1 FY2026 print already landed May 11; the next binary is the Q2 result around August 7, 2026 — the test of whether the 51% guidance raise holds. If you want the linear-motion-into-humanoid thesis with a confirmed humanoid partnership and a far cheaper multiple, the pivot is MinebeaMitsumi (6479) — its 18x multiple and ¥1.6 trillion diversified base make it the lower-risk way to own Japanese precision-motion humanoid optionality, leaving THK as the higher-beta, buy-the-dip-only expression. Conviction: 6 / 10.

Sources referenced inline throughout: THK FY2025 4Q investor information (February 12, 2026) and FY2026 1Q investor information (May 11, 2026); THK FY2026 guidance-raise disclosure; THK SEED Solutions and General-Purpose Gripper TRX product materials; 2026 humanoid-actuator engineering literature on planetary roller screws. Reference v1 of this template format: _Watchlist/hanmi-photoncap-style.md.

\newpage

NOVT — Novanta Inc. · WATCH (Tier-2) · Conv 6/10 · Bucket B

ticker: NOVT name: Novanta Inc. theme: Robotics bucket: B conviction: 6 entryzonelo: 146.93 entryzonehi: 162.39 currentprice: 154.66 pricedate: 2026-05-14 positionsizepct: 1.0 stoploss: 132.00 thesisoneline: A high-quality precision-motion and photonics compounder — encoders, end-of-arm tooling, beam steering — with real robotics/AI tailwinds, but a 37x multiple and only medical-half robotics exposure. catalystnext: Q2 CY2026 earnings catalystdate: 2026-08-04 rsi: 68.9 vs50ma: 21.7 forwardpe: 37.1 themecycleposition: early customermixsummary: Medical end-markets ~53% of revenue, advanced industrial ~47%; by segment Automation Enabling Technologies ~$501M and Medical Solutions ~$480M (FY2025). terminalriskoneline: A diversified precision-tech compounder where surgical robotics and industrial automation, not humanoids, drive the story — humanoid is a minor incremental tailwind, not the thesis. bulldriverscount: 5 gapriskscount: 4 optionalitycount: 5 lastearningsdate: 2026-05-11 nextearnings_date: 2026-08-04